[Antihistamine action of some synthetic antimalarial drugs]. 1951

E GENAZZANI, and I JAVICOLI

UI MeSH Term Description Entries
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D018926 Anti-Allergic Agents Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) Anti-Allergic,Anti-Allergic Agent,Anti-Allergy Drug,Antiallergic,Antiallergic Agent,Antiallergic Drug,Anti-Allergics,Anti-Allergy Drugs,Antiallergic Agents,Antiallergic Drugs,Antiallergics,Antiallergy Agents,Agent, Anti-Allergic,Agent, Antiallergic,Agents, Anti-Allergic,Agents, Antiallergic,Agents, Antiallergy,Anti Allergic,Anti Allergic Agent,Anti Allergic Agents,Anti Allergics,Anti Allergy Drug,Anti Allergy Drugs,Drug, Anti-Allergy,Drug, Antiallergic,Drugs, Anti-Allergy,Drugs, Antiallergic

Related Publications

E GENAZZANI, and I JAVICOLI
June 1956, The Journal of investigative dermatology,
E GENAZZANI, and I JAVICOLI
October 1967, Prensa medica argentina,
E GENAZZANI, and I JAVICOLI
October 1933, The Indian medical gazette,
E GENAZZANI, and I JAVICOLI
October 1948, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
E GENAZZANI, and I JAVICOLI
October 1947, Medicina,
E GENAZZANI, and I JAVICOLI
November 1957, The Journal of pharmacy and pharmacology,
E GENAZZANI, and I JAVICOLI
January 1952, Rassegna di fisiopatologia clinica e terapeutica,
E GENAZZANI, and I JAVICOLI
October 1948, Annals of internal medicine,
E GENAZZANI, and I JAVICOLI
August 1969, Polski tygodnik lekarski (Warsaw, Poland : 1960),
E GENAZZANI, and I JAVICOLI
November 1968, La Presse medicale,
Copied contents to your clipboard!